deferiprone has been researched along with Cancer of Cervix in 3 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We found that proliferation of cervical cancer cells can be blocked by DOHH inhibition with either of these pharmacologic agents, as well as by RNA interference-mediated silencing of eIF5A, DOHH, or another enzyme in the hypusine pathway." | 1.40 | Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation. ( Cracchiolo, B; Hanauske-Abel, HM; Heller, DS; Hoque, M; Jain, MR; Li, H; Mathews, MB; Mémin, E; Pe'ery, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mémin, E | 1 |
| Hoque, M | 1 |
| Jain, MR | 1 |
| Heller, DS | 1 |
| Li, H | 1 |
| Cracchiolo, B | 1 |
| Hanauske-Abel, HM | 1 |
| Pe'ery, T | 1 |
| Mathews, MB | 1 |
| Simonart, T | 2 |
| Boelaert, JR | 2 |
| Andrei, G | 2 |
| Clercq, ED | 1 |
| Snoeck, R | 2 |
| Mosselmans, R | 1 |
| Noel, JC | 1 |
| De Clercq, E | 1 |
3 other studies available for deferiprone and Cancer of Cervix
| Article | Year |
|---|---|
Blocking eIF5A modification in cervical cancer cells alters the expression of cancer-related genes and suppresses cell proliferation.
Topics: Antifungal Agents; Cell Proliferation; Ciclopirox; Deferiprone; Eukaryotic Translation Initiation Fa | 2014 |
Iron withdrawal strategies fail to prevent the growth of SiHa-induced tumors in mice.
Topics: Animals; Cell Division; Deferiprone; Deferoxamine; Female; Humans; Iron Chelating Agents; Iron, Diet | 2003 |
Antiproliferative and apoptotic effects of iron chelators on human cervical carcinoma cells.
Topics: Apoptosis; Cell Division; Deferiprone; Deferoxamine; Female; G1 Phase; Growth Inhibitors; HeLa Cells | 2002 |